Cargando…
Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders
Pathological fear and anxiety are highly debilitating and, despite considerable advances in psychotherapy and pharmacotherapy they remain insufficiently treated in many patients with PTSD, phobias, panic and other anxiety disorders. Increasing preclinical and clinical evidence indicates that pharmac...
Autores principales: | Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., Ressler, K.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380664/ https://www.ncbi.nlm.nih.gov/pubmed/25550231 http://dx.doi.org/10.1016/j.pharmthera.2014.12.004 |
Ejemplares similares
-
HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: where do we stand?
por: Whittle, Nigel, et al.
Publicado: (2014) -
129S1/SvImJ mice display impaired contextual fear extinction, enhanced fear incubation and deficit extinction consolidation phenotypes: rescue via pharmacological and non-pharmacological treatments
por: Whittle, Nigel, et al.
Publicado: (2011) -
Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model
por: Whittle, Nigel, et al.
Publicado: (2013) -
Histone deacetylase inhibitors, glutamatergic drugs and deep brain stimulation rescue resistance to fear extinction in a genetic mouse model
por: Whittle, Nigel, et al.
Publicado: (2012) -
Enhanced fear expression in a psychphathological mouse model of trait anxiety: pharmacological interventions
por: Hauschild, Markus, et al.
Publicado: (2010)